← Back to Search

Unified Protocol for Anxiety

N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female
Age 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months; administered at baseline, mid-treatment (6 weeks), post-treatment (12 weeks), and 3- and 6-month follow-up
Awards & highlights

Study Summary

This trial is testing whether a cognitive-behavioral therapy intervention can improve quality of life for women with pelvic floor disorders.

Eligible Conditions
  • Anxiety
  • Pelvic Floor Dysfunction
  • Urinary Urgency
  • Urinary Incontinence
  • Nocturia
  • Urinary Frequency/Urgency
  • Lower Urinary Tract Symptoms
  • Urinary Hesitancy
  • Urinary Straining

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months; administered at baseline, mid-treatment (6 weeks), post-treatment (12 weeks), and 3- and 6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months; administered at baseline, mid-treatment (6 weeks), post-treatment (12 weeks), and 3- and 6-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety
Fetal Distress
Secondary outcome measures
Fetal Distress
PROMIS Pain Intensity
Patient Global Impression of Improvement (PGI-I)
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Unified ProtocolExperimental Treatment1 Intervention
This is a type of CBT for emotional distress.
Group II: Supportive TherapyActive Control1 Intervention
This is a commonly-used form of all-purpose psychotherapy, often used as a comparator in CBT clinical trials.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Unified Protocol
2020
N/A
~390

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,577 Previous Clinical Trials
911,967 Total Patients Enrolled
20 Trials studying Anxiety
14,535 Patients Enrolled for Anxiety

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment still underway for this clinical investigation?

"As per data available on clinicaltrials.gov, the recruitment phase of this medical trial has been completed; therefore no new participants are being accepted at this time. The first posting was made on September 3rd 2018 and the most recent update happened in April 4th 2022. Nevertheless, there exist 579 other studies actively looking for volunteers."

Answered by AI

What do the researchers hope to conclude based on this experiment?

"This trial, which will span a period of about 7 days and involve assessments at baseline, mid-treatment (after 6 weeks), post-treatment (12 weeks) as well as 3 month and 6 months follow ups, is aiming to assess Urinary Distress Inventory (UDI-6). Secondary metrics being observed include Patient Reported Outcomes Measurement Information System's PROMIS 29 - Profile V2.0: Adult v1.0 Pain Interference 4a T Score measuring daily activity interference due to pain; Colorectal Anal Distress Inventory 8 (CRAD-8) assessing colorectal anal symptoms and"

Answered by AI
~6 spots leftby Mar 2025